AnaptysBio, Inc. (ANAB) vs Kardigan, Inc. (KARD)

A side-by-side comparison of AnaptysBio, Inc. and Kardigan, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ANAB vs KARD

growth of $100 · dividends reinvested · last 1y
ANAB -14.4% (-14.4%/yr)KARD -30.7% (-30.7%/yr)ANAB compounded faster over this window
80100120Start $100$86$69
ANAB KARD

ANAB vs KARD: by the numbers

  • •ANAB is the larger company ($1.41B vs $1.23B market cap).
  • •ANAB is profitable (82.37% net margin) while KARD runs a net loss (0.00%).

Metrics side by side

Valuation

MetricANABKARD
P/E ratio8.87N/A
P/S ratio5.93N/A
P/B ratio133.202.00
EV / EBITDA11.39N/A
FCF yield1.28%N/A

Profitability

MetricANABKARD
Gross margin98.97%0.00%
Operating margin20.42%0.00%
Net margin82.37%0.00%
ROE1849.06%N/A
ROIC47.55%-57.11%

Growth (annualized)

MetricANABKARD
Revenue CAGR (5Y)18.60%N/A
FCF CAGR (5Y)27.41%N/A
Total return CAGR (5Y)21.54%N/A

Frequently asked

Is ANAB or KARD more profitable?
ANAB runs the higher net margin — ANAB at 82.37% versus KARD at 0.00%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.